Clinical trial
Next Generation Sequencing Approach to the Study of Rheumatic Heart Disease
NCT02118818 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Next Generation Sequencing Approach to the Study of Rheumatic Heart Disease
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- July 31, 2024
- Enrollment
- 245 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.